资讯

SpinLaunch has completed a $30 million Series C funding round, led by ATW Partners and Norway's Kongsberg Defence and ...
Belite Bio (BLTE) recently announced the successful completion of the Phase 3 DRAGON clinical trial, which significantly focuses on treating Stargardt disease type 1. The company's share price ...